Posted by Michael Wonder on 02 Oct 2016
Schedule of Pharmaceutical Benefits - 1 October 2016 update
1 October 2016 - The 1 October 2016 issue of the Schedule of Pharmaceutical Benefits sees a number of new and revised listings.
The new/revised listings are:
- Aprepitant (Emend) - new indication
- Darunavir ethanolate with cobicistat (Prezcobix) - new combination product
- Secukinumab (Cosentyx) - two new indications
- Tamoxifen citrate (Nolvadex-D) - new indication
